Your browser doesn't support javascript.
loading
Curcumin and its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma.
Lu, Ko-Hsiu; Lu, Peace Wun-Ang; Lu, Eric Wun-Hao; Lin, Chiao-Wen; Yang, Shun-Fa.
Afiliación
  • Lu KH; Department of Orthopedics, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Lu PW; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
  • Lu EW; Morrison Academy Taichung, Taichung, Taiwan.
  • Lin CW; Department of Mechanical Engineering, College of Engineering, University of Michigan, Ann Arbor, MI, USA.
  • Yang SF; Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan.
Int J Biol Sci ; 19(4): 1241-1265, 2023.
Article en En | MEDLINE | ID: mdl-36923933
ABSTRACT
Curcumin is a natural polyphenol phytochemical derived from turmeric with antioxidant, anti-inflammatory, and anticancer properties but is concerned about poor solubility in water, absorption, and metabolic stability. Potent metastatic osteosarcoma is the most common primary bone cancer in children, adolescents, and young adults. It is responsible for low survival rates because of its high rate of metastasis to the lungs. To improve poor bioavailability, numerous curcumin analogs were developed to possess anticancer characteristics through a variety of biological pathways involved in cytotoxicity, proliferation, autophagy, sensitizing chemotherapy, and metastases. This review provides an overview of their various pharmacological functions, molecular mechanisms, and therapeutic potential as a remedy for human osteosarcoma. To enhance therapeutic efficacy, several liposomal nanoparticles, nanocarriers, multifunctional micelles, and three-dimensional printed scaffolds have also been developed for the controlled delivery of curcumin targeting human osteosarcoma cells. Consequently, curcumin and several potential analogs and delivery formulations are optimistic candidates to improve the currently available strategy for human osteosarcoma. However, further insight into the mechanism of action of promising curcumin analogs and the development of carriers in clinical trials of osteosarcoma needs to be investigated to improve their overall potency and clinical utility, in particular the anti-metastatic effect.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Óseas / Osteosarcoma / Curcumina / Nanopartículas Límite: Adolescent / Child / Humans Idioma: En Revista: Int J Biol Sci Asunto de la revista: BIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Óseas / Osteosarcoma / Curcumina / Nanopartículas Límite: Adolescent / Child / Humans Idioma: En Revista: Int J Biol Sci Asunto de la revista: BIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Taiwán